Discovering two new drugs that could save the lives of Corona patients
Friday – 25 Jumada I 1442 AH – January 08, 2021 AD
A nurse takes care of a patient with “Corona” in the intensive care unit in Spain (AFP)
London: “Middle East Online”
The researchers, who conducted a trial in the NHS’s intensive care units, say the anti-inflammatory drugs, given via a drip, save an extra life in every 12 patients undergoing treatment.
Experts say supplies are already available across the UK so they can be used immediately to save hundreds of lives.
There are more than 30,000 Covid-19 patients in UK hospitals – 39 per cent more than last April.
The UK government is working closely with the manufacturer to ensure the continued availability of the drugs – tocilizumab and sarilumab – for UK patients.
In addition to saving more lives, the treatments speed up the recovery of patients and reduce the time needed by critically ill patients in intensive care by about a week.
The two drugs seemed to work well and add to the benefit already found with the inexpensive steroid drug dexamethasone.
Although the drugs are not cheap, costing between £ 750 to £ 1,000 per patient, plus £ 5 for dexamethasone, the advantage of using them is clear – and less than the daily cost of an intensive care bed of roughly 2,000 pounds. Experts say.
“For every 12 patients we treat with these drugs, we expect a life to be saved,” said lead researcher Professor Anthony Gordon of Imperial College London. It’s a big impact. ”
And in an experiment conducted in six different countries, including the United Kingdom, with about 800 patients in intensive care, nearly 36 percent of Corona patients died in intensive care receiving standard care. The new drugs cut that by a quarter, to 27 percent, when given to patients within 24 hours of entering intensive care.
“The fact that there is now another drug that can help reduce deaths for patients with (Covid-19) is very welcome news and another positive development in the ongoing battle against the virus,” said Professor Stephen Boyce, National Medical Director for the National Health Service.
“The UK has proven time and time again that it is at the forefront of identifying and providing innovative and promising treatments for its patients,” said Minister of Health and Social Care Matt Hancock.
The drugs reduce inflammation in patients, which can damage the lungs and other organs.
Doctors are advised to give these two drugs to any critically ill patient, even if he is receiving dexamethasone.
The new corona virus